Table E2.
Baseline characteristics and clinical information of 78 convalescent patients with COVID-19
| Characteristic | Moderate (n = 26) | Severe (n = 43) | Critical (n = 9) | P value∗ |
|---|---|---|---|---|
| Age (y) (median, 25th-75th) | 64.5 (59.50-70.25) | 63.0 (56.00-68.00) | 67.0 (60.50-71.00) | .236 |
| Sex | ||||
| Female | 18 (69.23) | 24 (55.81) | 4 (44.44) | .311 |
| Male | 8 (30.77) | 19 (44.18) | 5 (55.56) | |
| Signs and symptoms at illness onset | ||||
| Fever | 16 (61.54) | 25 (58.14) | 7 (77.78) | .710 |
| Cough | 17 (65.38) | 30 (69.77) | 4 (44.44) | .624 |
| Chest distress | 5 (19.23) | 12 (27.90) | 2 (22.22) | .410 |
| Diarrhea | 7 (26.92) | 8 (18.60) | 1 (11.11) | .446 |
| Fatigue | 2 (7.69) | 6 (13.95) | 3 (33.33) | .569 |
| Shortness of breath | 1 (3.85) | 7 (16.28) | 2 (22.22) | .327 |
| Nausea and vomiting | 1 (3.85) | 1 (2.32) | 1 (11.11) | .674 |
| Headache | 0 | 2 (4.65) | 0 | .221 |
| Comorbidities | ||||
| Hypertension | 10 (38.46) | 14 (32.56) | 6 (66.67) | .518 |
| Diabetes | 2 (7.69) | 10 (23.26) | 2 (22.22) | .111 |
| Cardiovascular disease | 3 (11.54) | 3 (6.98) | 0 | .483 |
| Malignancy | 0 | 2 (4.65) | 1 (11.11) | .386 |
| Cerebrovascular disease | 0 | 0 | 2 (22.22) | .733 |
| Chronic kidney disease | 1 (0.38) | 0 | 0 | .180 |
| Tuberculosis | 1 (0.38) | 0 | 0 | .180 |
Data are presented as median (25th-75th) or numbers (%).
∗
P values indicate the differences among moderate, severe, and critical patients. P < .05 was considered statistically significant.